Sixteen Weeks of Supplementation with a Nutritional Quantity of a Diversity of Polyphenols from Foodstuff Extracts Improves the Health-Related Quality of Life of Overweight and Obese Volunteers: A Randomized, Double-Blind, Parallel Clinical Trial.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
02 Feb 2021
Historique:
received: 14 12 2020
revised: 25 01 2021
accepted: 28 01 2021
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 30 4 2021
Statut: epublish

Résumé

Overweight and obesity adversely affect health-related quality of life (HRQOL) through day-to-day impairments of both mental and physical functioning. It is assumed that polyphenols within the Mediterranean diet may contribute to improving HRQOL. This investigation aimed at studying the effects of a polyphenol-rich ingredient on HRQOL in overweight and obese but otherwise healthy individuals. A randomized, double-blind, placebo-controlled study including 72 volunteers was conducted. Subjects were randomly assigned to receive for a 16-week period either 900 mg/day of the supplement or a placebo. Dietary recommendations were individually determined and intakes were recorded. Daily physical mobility was also monitored. Improvement of HRQOL was set as the primary outcome and assessed at baseline and at the end of the investigation using the Short-Form 36 (SF-36) health survey. Body composition was analyzed using dual-energy X-ray absorptiometry (DXA). Physical activity was calculated using the International Physical Activity Questionnaire (IPAQ). After 16 weeks, despite there being no adherence to the Mediterranean Diet Serving Score (MDSS), supplemented individuals experienced significant HRQOL improvement (+5.3%;

Identifiants

pubmed: 33540841
pii: nu13020492
doi: 10.3390/nu13020492
pmc: PMC7913070
pii:
doi:

Substances chimiques

Placebos 0
Plant Extracts 0
Polyphenols 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 2011 Aug 27;378(9793):838-47
pubmed: 21872752
Nat Med. 2009 Sep;15(9):996-7
pubmed: 19734871
Pharmacoeconomics. 1999 Feb;15(2):141-55
pubmed: 10351188
JAMA. 1999 Dec 8;282(22):2136-42
pubmed: 10591335
Am J Manag Care. 2001 Sep;7(9):875-83
pubmed: 11570021
J Nutr. 2009 Sep;139(9):1788S-93S
pubmed: 19625699
Nutrients. 2018 Oct 17;10(10):
pubmed: 30336572
Int J Obes (Lond). 2012 Feb;36(2):295-303
pubmed: 21556045
PLoS One. 2015 Jun 02;10(6):e0128594
pubmed: 26035442
Obes Res. 2001 Jan;9(1):21-31
pubmed: 11346664
Am J Clin Nutr. 2016 Nov;104(5):1403-1409
pubmed: 27680996
Med Clin (Barc). 1998 Oct 10;111(11):410-6
pubmed: 9834913
Diabetes Nutr Metab. 2000 Jun;13(3):156-64
pubmed: 10963392
J Health Soc Behav. 1997 Mar;38(1):21-37
pubmed: 9097506
Int J Mol Sci. 2011;12(5):3117-32
pubmed: 21686173
Int J Mol Sci. 2020 Aug 06;21(16):
pubmed: 32781724
Am J Clin Nutr. 1984 Jul;40(1):168-82
pubmed: 6741850
Eat Behav. 2009 Apr;10(2):84-8
pubmed: 19447349
Health Qual Life Outcomes. 2006 Jul 17;4:43
pubmed: 16846509
Int J Mol Sci. 2010 Apr 13;11(4):1679-703
pubmed: 20480037
Mol Nutr Food Res. 2016 Jan;60(1):160-74
pubmed: 26577614
Public Health Nutr. 2011 Dec;14(12A):2274-84
pubmed: 22166184
Phytother Res. 2014 Feb;28(2):212-8
pubmed: 23554029
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Am J Clin Nutr. 2014 Dec;100(6):1489-97
pubmed: 25411284
Int J Food Sci Nutr. 2015 Feb;66(1):120-5
pubmed: 25358490
PLoS One. 2013 May 01;8(5):e61490
pubmed: 23658694
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
Obes Rev. 2001 Aug;2(3):173-82
pubmed: 12120102
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Nat Prod Rep. 2009 Aug;26(8):1001-43
pubmed: 19636448
Molecules. 2016 Sep 29;21(10):
pubmed: 27689985
Gac Sanit. 2005 Mar-Apr;19(2):135-50
pubmed: 15860162
Eur J Clin Nutr. 2012 Mar;66(3):360-8
pubmed: 21847137
BMC Med. 2014 May 13;12:77
pubmed: 24886552
Obesity (Silver Spring). 2012 Nov;20(11):2311-3
pubmed: 21633405
N Engl J Med. 1996 Mar 28;334(13):835-40
pubmed: 8596551
Obes Res. 1998 May;6(3):208-18
pubmed: 9618125
Prev Med. 2007 Dec;45(6):401-15
pubmed: 17707498
Br J Nutr. 2009 Dec;102(12):1790-802
pubmed: 19751534
Clin Obes. 2016 Aug;6(4):233-42
pubmed: 27198973
Diabetes. 2001 Jan;50(1):159-65
pubmed: 11147782
Endocr Metab Immune Disord Drug Targets. 2015;15(1):10-7
pubmed: 25612762
Obes Res. 2000 Mar;8(2):160-70
pubmed: 10757202
Biomed Imaging Interv J. 2008 Jan;4(1):e5
pubmed: 21614316
PLoS One. 2015 Oct 16;10(10):e0140599
pubmed: 26474291
BMJ Open. 2013 Aug 13;3(8):
pubmed: 23943771

Auteurs

Cindy Romain (C)

Innovation and Scientific Affairs, Fytexia, 34350 Vendres, France.

Linda H Chung (LH)

Research Center for High Performance Sport, Catholic University of Murcia, 30107 Murcia, Spain.

Elena Marín-Cascales (E)

Research Center for High Performance Sport, Catholic University of Murcia, 30107 Murcia, Spain.

Jacobo A Rubio-Arias (JA)

Research Center for High Performance Sport, Catholic University of Murcia, 30107 Murcia, Spain.

Sylvie Gaillet (S)

UMR 204 Nutripass, Research Institute for Development, University of Montpellier, 34095 Montpellier, France.

Caroline Laurent (C)

UMR 204 Nutripass, Research Institute for Development, University of Montpellier, 34095 Montpellier, France.

Juana María Morillas-Ruiz (JM)

Department of Food and Nutrition Technology, Catholic University of Murcia, 30107 Murcia, Spain.

Alejandro Martínez-Rodriguez (A)

Research Center for High Performance Sport, Catholic University of Murcia, 30107 Murcia, Spain.

Pedro Emilio Alcaraz (PE)

Research Center for High Performance Sport, Catholic University of Murcia, 30107 Murcia, Spain.

Julien Cases (J)

Innovation and Scientific Affairs, Fytexia, 34350 Vendres, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH